Universal Health (UHS) Reports In-Line Q4 EPS; Guides In-Line to Slightly Better

Universal Health (NYSE: UHS) reported Q4 EPS of $1.74, in-line with the analyst estimate of $1.74. Revenue for the quarter came in at $2.32 billion versus the consensus estimate of $2.29 billion.

GUIDANCE:

Universal Health sees FY2016 EPS of $7.12-$7.58, versus the consensus of $7.42. Universal Health sees FY2016 revenue of $9.75-9.85 billion, versus the consensus of $9.66 billion.

For earnings history and earnings-related data on Universal Health (UHS) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30
• INVO Fertility (IVF) Tops Q2 EPS by 105c